Literature DB >> 2415248

Epitopes of carcinoembryonic antigen defined by monoclonal antibodies prepared from mice immunized with purified carcinoembryonic antigen or HCT-8R cells.

A Haggarty, C Legler, M J Krantz, A Fuks.   

Abstract

A library of 18 monoclonal antibodies (MAbs) reactive with purified carcinoembryonic antigen (CEA) has been prepared. The specificity of these MAbs was tested and they have been separated into nine subgroups, each recognizing a different region of the CEA molecule. Seven MAbs from four of the groups also react with the nonspecific cross-reacting antigen. Some of the MAbs are directed against conformational determinants: three of the MAb groups bind poorly to sodium dodecyl sulfate-treated CEA, while five of the groups are not reactive with reduced and alkylated CEA. Three of the groups react with purified CEA but not with the cell surface CEA of HCT-8R cells, while the other groups react with both forms. The MAbs were tested for binding to fragments of CEA obtained by chemical cleavage and the groups of MAbs were found to react with different subsets of such fragments.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2415248

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  D-14 monoclonal antibody to carcinoembryonic antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human colorectal carcinoma, tumors of non-colorectal origin and normal tissues.

Authors:  Z P Pavelic; N J Petrelli; L Herrera; M M Vaughan; J S Paecock; L Pavelic
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Biosynthesis and glycosylation of the carcinoembryonic antigen.

Authors:  C Mottola-Hartshorn; P Lorenzoni; C Ceccarini
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

3.  Molecular cloning of a gene belonging to the carcinoembryonic antigen gene family and discussion of a domain model.

Authors:  J A Thompson; H Pande; R J Paxton; L Shively; A Padma; R L Simmer; C W Todd; A D Riggs; J E Shively
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  A colonic tissue architecture assay applied to human colon carcinoma cells.

Authors:  C Ilantzis; C P Stanners
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-01       Impact factor: 2.416

5.  Soluble isoforms of CEACAM1 containing the A2 domain: increased serum levels in patients with obstructive jaundice and differences in 3-fucosyl-N-acetyl-lactosamine moiety.

Authors:  L Dráberová; H Cerná; H Brodská; M Boubelík; S M Watt; C P Stanners; P Dráber
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

6.  Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation.

Authors:  Christian Ilantzis; Luisa DeMarte; Robert A Screaton; Clifford P Stanners
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

7.  Isolation and characterization of full-length functional cDNA clones for human carcinoembryonic antigen.

Authors:  N Beauchemin; S Benchimol; D Cournoyer; A Fuks; C P Stanners
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

8.  Diverse characteristics of 111In labelled anti-CEA monoclonal antibodies for tumour immunoscintigraphy: radiolabelling, biodistribution and imaging studies in mice with human tumour xenografts.

Authors:  M V Pimm; A C Perkins; R W Baldwin
Journal:  Eur J Nucl Med       Date:  1987

9.  Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.

Authors:  G Bepler; G Jaques; A Koehler; C Gropp; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

10.  Mapping of monoclonal antibody-defined epitopes associated with carcinoembryonic antigen, CEA.

Authors:  M R Price; S Edwards; E Jacobs; I Z Pawluczyk; V S Byers; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.